Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Costello Syndrome | 5 | 2019 | 18 | 1.720 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2022 | 830 | 1.580 |
Why?
|
| Neurocognitive Disorders | 2 | 2020 | 69 | 1.230 |
Why?
|
| Neuropsychological Tests | 5 | 2019 | 1178 | 1.070 |
Why?
|
| Urogenital Abnormalities | 2 | 2020 | 174 | 1.070 |
Why?
|
| Patient Compliance | 5 | 2017 | 667 | 1.020 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 45 | 0.760 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 59 | 0.760 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 112 | 0.710 |
Why?
|
| Dwarfism | 1 | 2020 | 109 | 0.710 |
Why?
|
| Social Behavior | 2 | 2019 | 306 | 0.700 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 573 | 0.680 |
Why?
|
| Brain Infarction | 1 | 2019 | 31 | 0.670 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 239 | 0.660 |
Why?
|
| Cognition Disorders | 3 | 2015 | 786 | 0.600 |
Why?
|
| Developmental Disabilities | 2 | 2020 | 674 | 0.560 |
Why?
|
| Executive Function | 2 | 2016 | 160 | 0.550 |
Why?
|
| Ectromelia | 1 | 2015 | 6 | 0.530 |
Why?
|
| Aftercare | 1 | 2017 | 259 | 0.520 |
Why?
|
| Encephalocele | 1 | 2015 | 53 | 0.510 |
Why?
|
| Hyperglycemia | 2 | 2014 | 333 | 0.480 |
Why?
|
| Survivors | 2 | 2017 | 1031 | 0.480 |
Why?
|
| Adaptation, Psychological | 4 | 2013 | 764 | 0.450 |
Why?
|
| Verbal Learning | 1 | 2013 | 84 | 0.450 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 998 | 0.440 |
Why?
|
| Models, Psychological | 1 | 2013 | 170 | 0.430 |
Why?
|
| Cognition | 2 | 2016 | 968 | 0.430 |
Why?
|
| Child Development | 1 | 2014 | 255 | 0.420 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2013 | 136 | 0.410 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 363 | 0.410 |
Why?
|
| Behavioral Symptoms | 1 | 2011 | 32 | 0.390 |
Why?
|
| Neuroimaging | 1 | 2014 | 403 | 0.390 |
Why?
|
| Adolescent | 16 | 2022 | 31252 | 0.370 |
Why?
|
| Memory | 1 | 2013 | 429 | 0.360 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 846 | 0.360 |
Why?
|
| Psychomotor Performance | 3 | 2016 | 233 | 0.350 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1331 | 0.350 |
Why?
|
| Phenotype | 3 | 2020 | 6295 | 0.330 |
Why?
|
| Child, Preschool | 8 | 2020 | 16273 | 0.320 |
Why?
|
| Stress, Psychological | 2 | 2014 | 1000 | 0.320 |
Why?
|
| Brain | 2 | 2019 | 4113 | 0.310 |
Why?
|
| Child | 13 | 2022 | 29154 | 0.300 |
Why?
|
| Hypoglycemia | 2 | 2022 | 213 | 0.300 |
Why?
|
| Heart Defects, Congenital | 2 | 2019 | 1697 | 0.270 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 586 | 0.270 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 666 | 0.260 |
Why?
|
| Insulin | 1 | 2010 | 1454 | 0.240 |
Why?
|
| Insulins | 1 | 2022 | 18 | 0.210 |
Why?
|
| Mass Screening | 1 | 2011 | 1509 | 0.210 |
Why?
|
| Self-Management | 1 | 2022 | 89 | 0.190 |
Why?
|
| Male | 16 | 2022 | 123000 | 0.190 |
Why?
|
| Risk Factors | 6 | 2017 | 17523 | 0.180 |
Why?
|
| Young Adult | 7 | 2020 | 21445 | 0.180 |
Why?
|
| Humans | 23 | 2022 | 261506 | 0.160 |
Why?
|
| Reaction Time | 1 | 2016 | 234 | 0.130 |
Why?
|
| Infant | 3 | 2017 | 13310 | 0.130 |
Why?
|
| Crohn Disease | 2 | 2016 | 351 | 0.130 |
Why?
|
| Neoplasms | 2 | 2022 | 15193 | 0.130 |
Why?
|
| Cancer Survivors | 1 | 2022 | 650 | 0.130 |
Why?
|
| Attention | 1 | 2016 | 281 | 0.120 |
Why?
|
| Alleles | 1 | 2020 | 2437 | 0.120 |
Why?
|
| Visual Perception | 1 | 2015 | 154 | 0.120 |
Why?
|
| Female | 13 | 2022 | 141928 | 0.120 |
Why?
|
| Infant, Newborn | 2 | 2017 | 8223 | 0.120 |
Why?
|
| Language Tests | 1 | 2013 | 27 | 0.120 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 268 | 0.110 |
Why?
|
| Amino Acids | 1 | 2016 | 728 | 0.110 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2013 | 94 | 0.110 |
Why?
|
| Arginine | 1 | 2016 | 500 | 0.110 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 136 | 0.110 |
Why?
|
| Heart | 1 | 2019 | 1223 | 0.110 |
Why?
|
| Colon | 1 | 2016 | 670 | 0.110 |
Why?
|
| Age of Onset | 1 | 2014 | 827 | 0.110 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2015 | 406 | 0.110 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 6 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2014 | 362 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 4298 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2015 | 291 | 0.100 |
Why?
|
| Fathers | 1 | 2012 | 68 | 0.100 |
Why?
|
| Disease Management | 2 | 2019 | 1052 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 4314 | 0.100 |
Why?
|
| Placenta | 1 | 2015 | 516 | 0.100 |
Why?
|
| Adult | 8 | 2022 | 77950 | 0.100 |
Why?
|
| Psychology | 1 | 2011 | 86 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2013 | 1945 | 0.090 |
Why?
|
| ROC Curve | 1 | 2013 | 1183 | 0.090 |
Why?
|
| Age Factors | 2 | 2017 | 5377 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 257 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2016 | 6100 | 0.090 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 108 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2014 | 1244 | 0.090 |
Why?
|
| Family Relations | 1 | 2010 | 88 | 0.090 |
Why?
|
| Behavior | 1 | 2009 | 103 | 0.090 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 4320 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 598 | 0.080 |
Why?
|
| Mothers | 1 | 2012 | 410 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 773 | 0.080 |
Why?
|
| Parenting | 1 | 2012 | 345 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 360 | 0.080 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 5687 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 5539 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2016 | 1237 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 6009 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 1054 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2016 | 6150 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 1225 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1148 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 2139 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2011 | 2292 | 0.070 |
Why?
|
| Hospitalization | 1 | 2014 | 2083 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2019 | 37905 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 14889 | 0.060 |
Why?
|
| Parents | 1 | 2011 | 998 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2013 | 9244 | 0.060 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.060 |
Why?
|
| Biomarkers | 1 | 2014 | 5047 | 0.050 |
Why?
|
| Texas | 1 | 2013 | 6311 | 0.050 |
Why?
|
| Time Factors | 1 | 2016 | 12926 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 4971 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 4892 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2022 | 133 | 0.050 |
Why?
|
| Survivorship | 1 | 2022 | 109 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2013 | 6869 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7551 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 7702 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 383 | 0.040 |
Why?
|
| Amino Acid Transport Systems, Basic | 1 | 2016 | 13 | 0.040 |
Why?
|
| Face | 1 | 2019 | 273 | 0.040 |
Why?
|
| Diet Records | 1 | 2016 | 77 | 0.040 |
Why?
|
| Arginase | 1 | 2016 | 48 | 0.030 |
Why?
|
| Biological Availability | 1 | 2016 | 214 | 0.030 |
Why?
|
| Caregivers | 1 | 2022 | 677 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 261 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 3260 | 0.030 |
Why?
|
| Citrulline | 1 | 2016 | 108 | 0.030 |
Why?
|
| Mutation | 2 | 2011 | 15179 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1046 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 698 | 0.030 |
Why?
|
| Safety | 1 | 2015 | 465 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2015 | 164 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2015 | 1290 | 0.030 |
Why?
|
| Southwestern United States | 1 | 2011 | 62 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 4109 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 445 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2015 | 2588 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1323 | 0.020 |
Why?
|
| Remission Induction | 1 | 2015 | 3569 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 2009 | 157 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 4053 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 937 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 417 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 5637 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 3719 | 0.020 |
Why?
|
| Motor Activity | 1 | 2009 | 693 | 0.020 |
Why?
|
| Depression | 1 | 2015 | 1715 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 2803 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 5673 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 7573 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2016 | 12873 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 4532 | 0.010 |
Why?
|
| Aging | 1 | 2009 | 1582 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 21713 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 32848 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 70117 | 0.010 |
Why?
|